سعر بريسجزما 0.5% قطرة للعين 5مل 2022

Pressgoma 0.5% eye drops 5 ml (Alexandria Co.), betaxolol cardioselective beta-1 blocker for raised intraocular pressure.

• Treatment of ocular hypertension and chronic open-angle glaucoma, alone or with other antiglaucoma drugsDailyMed (U.S. National Library of Medicine)

• Transient ocular discomfort in about one in four patients; occasional tearing; rarely decreased corneal sensitivity, erythema, itching, keratitis, photophobia; rare systemic bradycardia, heart block, bronchospasm, insomnia, dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component; sinus bradycardia, greater than first-degree AV block, cardiogenic shock, overt cardiac failure.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Topical beta-blockers may be absorbed systemically: severe respiratory (bronchospasm in asthma) and cardiac reactions reported; caution in cardiac failure or heart block, discontinue at first signs of cardiac failure; caution in severe reactive airway disease.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Oral beta-blockersPotential additive effect on intraocular pressure or systemic beta-blockade.DailyMed (U.S. National Library of Medicine)
• Catecholamine-depleting drugs (e.g. reserpine)Possible additive hypotension and/or bradycardia.DailyMed (U.S. National Library of Medicine)

• No adequate studies in pregnant women; postimplantation loss in animals at high oral doses; use only if potential benefit justifies risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Betaxolol: Selective beta-1 blocker that lowers intraocular pressure when instilled in the eye (US label).